Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03588624 · ClinicalTrials.gov registry record · NA
Study of the TearCare System in Dry Eye Disease
A NA study of Dry Eye, sponsored by Sight Sciences.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
- 3
- Study locations
NCT03588624: Completed NA study of Dry Eye, sponsored by Sight Sciences.
NCT03588624 is a NA study of Dry Eye that has completed, run by Sight Sciences. The registered enrollment target is 29 participants, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (69% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03588624, a NA study of Dry Eye, has completed, sponsored by Sight Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study was conducted to evaluate the short-term (1 month) safety and effectiveness of a single TearCare procedure to treat adult patients with dry eye disease.
Primary Outcome
TBUT is an indicator of tear film instability and measures the length of time it takes for the tear film to break down. An increase in TBUT represents an improvement.
Conditions Studied
Interventions
- DEVICE TearCare
Study Locations (3)
California
- Eye Research Institute - Newport Beach
Illinois
- Arlington Eye Physicians - Arlington Heights
Kentucky
- Kentucky Eye Institute - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2018-07-12 |
| Est. Completion | 2018-11-08 |
| Phase | NA |
What the finished NCT03588624 record still lists
NCT03588624 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 29 participants, a relatively small participant target, below the 95-participant average among 41 other Dry Eye trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Dry Eye appearing as the primary indexed condition, and to 1 intervention - of which TearCare is the first listed.
NCT03588624 reports a single indexed study location in California, Illinois, Kentucky.
Frequently Asked Questions
What is clinical trial NCT03588624 about?
NCT03588624 is a clinical study titled "Study of the TearCare System in Dry Eye Disease". This study was conducted to evaluate the short-term (1 month) safety and effectiveness of a single TearCare procedure to treat adult patients with dry eye disease.
What is the current status of trial NCT03588624?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2018-07-12. Estimated completion is 2018-11-08.
What conditions does trial NCT03588624 study?
This clinical trial studies the following conditions: Dry Eye.
What interventions are being tested in trial NCT03588624?
The interventions under investigation include: TearCare (DEVICE).
Who is sponsoring clinical trial NCT03588624?
This trial is sponsored by Sight Sciences, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03588624 being conducted?
This trial has 3 study locations across California, Illinois, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dry Eye
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03588624's enrollment target sits among peer trials
29 34th of 41 higher than 8 of 41 other Dry Eye trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dry Eye trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The THINK Study Incidence of Neurotrophic Keratopathy)
RECRUITING · NA
-
Low Level Light Therapy & Skin Pigmentation
RECRUITING · NA
-
Corneal Epithelial Stem Cells and Dry Eye Disease
COMPLETED · NA
-
Acute Comfort of Lubricant Eye Drops FID 112903
COMPLETED · NA
-
Evaluation of Extended Tear Film Break Up Time (TFBUT) With an Ocular Emulsion
COMPLETED · NA
-
Efficacy of IPL Treatment of Dry Eye and Ocular Rosacea
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI